The efficacy of modern antiviral therapies, particularly those used to combat HIV, hinges on the precise synthesis of complex molecular structures. Dolutegravir, a cornerstone medication in HIV treatment, exemplifies this reliance on sophisticated chemical synthesis, underpinned by essential building blocks. Among these, (4R,12aS)-7-Methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-9-carboxylic acid (CAS: 1335210-34-8) stands out as a critical intermediate.

This specific organic compound, often described as a white to light yellow powder with a purity assay of ≥98%, plays a pivotal role in the multi-step process that leads to the formation of Dolutegravir. Its defined stereochemistry and functional groups are crucial for ensuring that the final API exhibits the correct biological activity. The molecular formula C14H16N2O6 and molecular weight of 308.287 g/mol are not just identifiers but fundamental properties that chemists rely on for reaction planning and optimization.

For pharmaceutical companies engaged in the production of Dolutegravir, securing a reliable source for this intermediate is a strategic imperative. The ability to buy this compound from a consistent and quality-focused manufacturer is essential for maintaining production pipelines and ensuring patient access to treatment. We, as a dedicated chemical manufacturer and supplier, are committed to providing this vital building block to the pharmaceutical industry. Our expertise in fine chemical synthesis, coupled with our manufacturing presence in China, allows us to offer this product with guaranteed purity and competitive pricing for bulk orders.

Understanding the chemical foundations of potent drugs like Dolutegravir highlights the importance of specialized chemical intermediates. We are proud to contribute to global health by supplying high-quality precursors that enable the production of essential antiviral therapies. For any inquiries regarding (4R,12aS)-7-Methoxy-4-methyl-6,8-dioxo-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-9-carboxylic acid, or other pharmaceutical intermediates, we encourage you to reach out to our expert team.